KD Logo

ARCA biopharma Inc [ABIO] Records 200-Day SMA of $2.55

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ARCA biopharma Inc shares valued at $17,067 were purchased by JANUS HENDERSON GROUP PLC on Aug 16 ’24. At $2.93 per share, JANUS HENDERSON GROUP PLC acquired 5,818 shares. The insider’s holdings grew to 2,117,213 shares worth approximately $5.29 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, JANUS HENDERSON GROUP PLC purchased 189,856 shares, netting a total of over 606,873 in proceeds. Following the buying of shares at $3.20 each, the insider now holds 2,081,168 shares.

Before that, JANUS HENDERSON GROUP PLC had added 30,227 shares to its account. In a trade valued at $92,292, the 10% Owner bought ARCA biopharma Inc shares for $3.05 each. Upon closing the transaction, the insider’s holdings increased to 30,227 shares, worth approximately $5.28 million.

As published in their initiating research note from Ascendiant Capital Markets on February 27, 2018, ARCA biopharma Inc [ABIO] has been a Buy and the price target has been revised to $2. Analysts at Dawson James started covering the stock with ‘”a Buy”‘ outlook in a report released in early October.

Analyzing ABIO Stock Performance

During the last five days, there has been a surge of approximately 18.58%. Over the course of the year, ARCA biopharma Inc shares have jumped approximately 173.43%. Shares of the company reached a 52-week high of $4.49 on 05/17/24 and a 52-week low of $1.56 on 01/19/24. A 50-day SMA is recorded $3.31, while a 200-day SMA reached $2.55. Nevertheless, trading volume fell to 2.2 million shares from 0.19 million shares the previous day.

Support And Resistance Levels for ARCA biopharma Inc (ABIO)

According to the 24-hour chart, there is a support level at 1.96, which, if violated, would cause prices to drop to 1.41. In the upper region, resistance lies at 2.90. The next price resistance is at 3.29. RSI (Relative Strength Index) is 69.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.06, which suggests the price will decrease in the coming days. Percent R is at 72.94%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular